Supplementary Figure S1 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Figure S2 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma2025
2. 2Supplementary Figure S3 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma2025
3. 3Supplementary Figure S5 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma2025
4. 4Supplementary Figure S9 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma2025
5. 5Supplementary Figure S8 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma2025